EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved efficacy of an influenza DNA vaccine through high-density microarray patch delivery

Chloe G Entriken, Kimberley L Bruce, Bridget M Coyne, Saxon H Kruyer, Jane E Sinclair, Jovin J Y Choo, David A Muller, Christopher L D McMillan

Journal of General Virology · 14.11.2025 · 106 (11)

DOI: 10.1099/jgv.0.002179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Virology, erschienen am 14.11.2025. Verfasst von Chloe G Entriken und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, 4072, Australia. Hauptthemen laut MEDLINE: Vaccines, DNA, Influenza Vaccines, Influenza A Virus, H1N1 Subtype, Hemagglutinin Glycoproteins, Influenza Virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Advance Queensland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pandemic preparedness requires vaccine platforms that are fast to produce, thermostable and suitable for broad deployment. DNA vaccines are well suited to this task but have historically suffered from poor immunogenicity when delivered by conventional intramuscular (IM) injection. Here, we evaluated high-density microarray patch (HD-MAP) delivery of a DNA vaccine encoding the influenza A/California/01/2009 (H1N1pdm09) haemagglutinin (HA) antigen. In vivo imaging of a luciferase reporter construct demonstrated earlier and higher expression following HD-MAP application compared to IM injection. HD-MAP delivery of the HA vaccine induced strong HA-specific IgG responses, whereas IM delivery did not. Upon challenge with a homologous H1N1 virus, all HD-MAP-vaccinated mice were protected from weight loss, while 50% of intramuscularly vaccinated mice met humane endpoints. These findings support the use of HD-MAPs to overcome delivery limitations of DNA vaccines and enhance their utility for future outbreak and pandemic response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccines, DNAInfluenza VaccinesInfluenza A Virus, H1N1 SubtypeHemagglutinin Glycoproteins, Influenza VirusOrthomyxoviridae InfectionsMicroarray AnalysisAnimalsMiceAntibodies, ViralFemaleMice, Inbred BALB CInjections, IntramuscularHumansImmunoglobulin GVaccination

Stichwörter der Autor:innen

influenzamicroarray patchpandemicvaccine

Substanzen

Vaccines, DNAInfluenza VaccinesHemagglutinin Glycoproteins, Influenza VirusAntibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, 4072, Australia.
  • Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, 4072, Australia.

Förderung

  • Advance Queensland

Zitieren

APA

Entriken, C. G., Bruce, K. L., Coyne, B. M., Kruyer, S. H., Sinclair, J. E., Choo, J. J. Y., Muller, D. A., & McMillan, C. L. D. (2025). Improved efficacy of an influenza DNA vaccine through high-density microarray patch delivery. Journal of General Virology, 106(11). https://doi.org/10.1099/jgv.0.002179

Vancouver

Entriken CG, Bruce KL, Coyne BM, Kruyer SH, Sinclair JE, Choo JJY, et al. Improved efficacy of an influenza DNA vaccine through high-density microarray patch delivery. Journal of General Virology. 2025;106(11). doi:10.1099/jgv.0.002179

BibTeX
@article{Entriken2025,
  author = {Entriken, Chloe G and Bruce, Kimberley L and Coyne, Bridget M and Kruyer, Saxon H and Sinclair, Jane E and Choo, Jovin J Y and Muller, David A and McMillan, Christopher L D},
  title = {Improved efficacy of an influenza DNA vaccine through high-density microarray patch delivery},
  journal = {Journal of General Virology},
  year = {2025},
  volume = {106},
  number = {11},
  doi = {10.1099/jgv.0.002179}
}
Kostenlos starten →